Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 1/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 1/20 | 0.42 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.36 |
| ▸ | FABP7 | O15540 | 2/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | MDM4 | O15151 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | ACACB | O00763 | 1/20 | 0.35 |
| ▸ | CASP3 | P42574 | 1/20 | 0.35 |
| ▸ | CTSL | P07711 | 1/20 | 0.35 |
| ▸ | CTSK | P43235 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15632803 | 1.00 | ITGB3 (0.45) | ITGB3ITGA2BPPARGPPARAFABP5 | |
| SCHEMBL17265629 | 1.00 | ITGB3 (0.45) | ITGB3ITGA2BPPARGPPARAFABP5 | |
| SCHEMBL31437117 | 1.00 | ITGB3 (0.45) | ITGB3ITGA2BPPARGPPARAFABP5 | |
| SCHEMBL31037194 | 1.00 | ITGB3 (0.45) | ITGB3ITGA2BPPARGPPARAFABP5 | |
| SCHEMBL16482875 | 0.91 | ITGB3 (0.39) | ITGB3ITGA2BPPARGPPARAFABP5 | |
| SCHEMBL25185646 | 0.91 | ITGB3 (0.45) | ITGB3ITGA2BPPARGPPARAFABP5 | |
| SCHEMBL25185647 | 0.91 | ITGB3 (0.45) | ITGB3ITGA2BPPARGPPARAFABP5 | |
| SCHEMBL29855055 | 0.91 | ITGB3 (0.45) | ITGB3ITGA2BPPARGPPARAFABP5 | |
| SCHEMBL25357586 | 0.89 | ITGB3 (0.40) | ITGB3ITGA2BPPARGPPARAFABP5 | |
| SCHEMBL25357591 | 0.89 | ITGB3 (0.40) | ITGB3ITGA2BPPARGPPARAFABP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3647319-B1 | PEPTIDE COMPOUND, APPLICATION THEREOF AND COMPOSITION CONTAINING SAME | XDCEXPLORER SHANGHAI CO LTD (CN) | 2025-04-09 | — | — | EP | disclosed |
| US-12129312-B2 | Peptide compound, application thereof and composition containing same | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2024-10-29 | — | — | US | disclosed |
| US-20240209023-A1 | PEPTIDE COMPOUND, APPLICATION THEREOF AND COMPOSITION CONTAINING SAME | XDCEXPLORER (SHANGHAI) CO., LTD. (CN) | 2024-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12129312-B2 | Peptide compound, application thereof and composition containing same | VIP, NGLY1, FURIN | ITGB3 4612/4885ITGA2B 4738/4885PPARG 4226/4885 |
| US-20240209023-A1 | PEPTIDE COMPOUND, APPLICATION THEREOF AND COMPOSITION CONTAINING SAME | VIP, NGLY1, FURIN | ITGB3 4490/4885ITGA2B 4681/4885PPARG 3852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.